Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, November 11 at 2:00 PM ET

Register Free →

This Government Contract opportunity was posted on October 2, 2018. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Investigational Drug Management System

Awarded
NIH-CC-18-002794Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

AI Contract Overview

Show more

The National Institute of Health is seeking a commercially available Investigational Drug Management System for the NIH Clinical Center Pharmacy Department. This acquisition is set aside exclusively for small businesses under NAICS code 541511 for Custom Computer Programming Services. The government intends to award a fixed price purchase order, and offerors may include separately priced line items for additional options or upgrades. Responses are due by May 25, 2018, at 9:00 a.m. ET. Applicants must acknowledge receipt of Amendment 1 and Amendment 2 to be considered. Required submission materials include a high level project plan and a completed technical questionnaire, which is weighted with a total of 45 possible points for evaluation. While a detailed project plan and quality assurance plan are not required for the initial submission, both must be provided within 30 days of the contract award.

General Info

Agency

N/A

Contract Value

$0

NAICS

541511 - Custom Computer Programming Services

Place of Performance

NIH Clinical Center 9000 Rockville Pike, BETHESDA, MD, 20892, USA

Set-Aside

NONE

Award Issued Date

Documents

0

No documents available

Documents will appear here when they are available.

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

Timeline

4 updates
PhaseAwarded
Posted

Sources Sought

Notice updated

The notice description changed.

Notice updated

Response deadline changed from Dec 7, 2017 to Dec 13, 2017. The notice description changed.

Type Changed

Sources Sought → Combined Synopsis

Notice updated

Response deadline changed from May 16, 2018 to May 23, 2018. The notice description changed.

Notice updated

The notice description changed.

Awarded

Contract was awarded

Submission Closed

Find active opportunities like this

Get full access to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyN/A
Contacts1 person available
OfficeN/A
Organization / Agency
N/A
Office AddressN/A
Contacts
Lisa L. SchauppContract Specialist

Full Description

Show more
PLEASE NOTE: The closing date of this Sources Sought Notice is extended to December 13, 2017 from December 7, 2017. The time is still 9:00 a.m. ET. The National Institutes of Health ("NIH"), Clinical Center is conducting a market survey/sources sought notice to determine whether there is a reasonable expectation of a responsible/capable offeror to provide an Investigational Drug Management System with, at least, the characteristics listed below. Accordingly, NIH is hoping that there exists a reasonable expectation of at least two responsible/capable offerors in order for NIH to compete the requirement. Additionally, NIH is attempting to ascertain if there exists a reasonable expectation of at least two responsible/capable small business offerors in order for NIH to compete the requirement as a small business set aside. Accordingly, NIH is seeking capability statements as to the attached SOW from other-than-small businesses, small businesses, veteran-owned small businesses, service disabled veteran-owned small businesses, HUBZONE small businesses, small businesses under the 8(a) program, and/or businesses under the GSA Schedule capable of providing a system with the following performance characteristics. The Investigational Drug Management Service Software System must be capable of providing the following. - Inventory management of all investigational drugs and protocols - Accountability records generation - Barcoding of investigational drug products - Document storage capabilities - Ability to set up double blinded studies - Ability to track the ordering of drug and receiving from an ordering queue - Drug expiration tracking - HL7 integration with Allscripts - Quality Analytics and Reporting capabilities - Active Directory functionality support - Ability to host server at the Clinical Center THIS MARKET SURVEY/SOURCES SOUGHT ANNOUNCEMENT IS NOT A REQUEST FOR PROPOSALS, AND THE GOVERNMENT IS NOT COMMITTED TO AWARD A CONTRACT PURSUANT TO THIS ANNOUNCEMENT. CONSEQUENTLY, DO NOT SEND A PROPOSAL IN RESPONSE TO THIS NOTICE. THE APPROPRIATE RESPONSE IS A CAPABILITY STATEMENT. ALTHOUGH A RESPONDENT CAN RESPOND WITH WHATEVER INFORMATION THE RESPONDENT SEES FIT, THE IDEAL CAPABILITY STATEMENT SPECIFICALLY ADDRESSES THE REQUIREMENTS IN THE SOW AND THE REQUESTS FOR INFORMATION BELOW, AND IS NOT A GENERIC SALES BROCHURE OR MARKETING HANDOUT. FURTHER, THE GOVERNMENT REQUESTS, BUT DOES NOT MANDATE, THAT THE CAPABILITY STATEMENT IS LIMITED TO NO MORE THAN TEN PAGES. ANY PROPRIETARY INFORMATION IN THE SUBMITTED CAPABILITY STATEMENT SHOULD BE CLEARLY MARKED AS SUCH. The information obtained from this market research is for Government planning purposes only, and will assist the Government in planning its acquisition strategy. This is strictly market research, and the Government is not opening a question and answer period concerning this market research. Further, the Government will not pay for any costs incurred in the preparation of information in response to this market survey. In addition to addressing the requirements listed above, the Government requests that your capability statement address the following requests for information, if relevant. 1) Please provide the full company/entity name, address including points of contact (phone number and e-mail address), DUNS numbers, and type/size of the company/entity by NAICS code. 2) If your company/entity is a dealer or service-provider, and not a manufacturer of the end items/products contemplated by the SOW, please identify your company as such and identify the end item/product manufacturers that you would be obtaining goods from in order to perform the contract, and where the manufacturers are geographically located. 3) According to the small business limitations on subcontracting standard provided by the amended Small Business Act at 15 U.S.C. - 657s, the requirement for a small business supplier is that the small business prime contractor "may not expend on subcontractors more than 50 percent of the amount, less the cost of materials, paid to the concern under the contract . . . ." 15 U.S.C. - 657s(a)(2). However, "[c]ontract amounts expended by a covered small business concern on a subcontractor that is a similarly situated entity [(i.e., another small/small disadvantaged business of the same type)] shall not be considered subcontracted for purposes of determining whether the covered small business concern has violated [limitations on subcontracting.]" 15 U.S.C. - 657s(b). If you are a small business, please address your ability to adhere to limitations on subcontracting at 15 U.S.C. - 657s. To ascertain if you are a small business, use the size standard provided by NAICS Code 541513 (Computer System Design Services), with a size standard of no more than $27.5 Million. As part of this, if you are a small business that is a dealer/service-provider and not a manufacturer, please so state, and address whether you meet the following requirements from 13 C.F.R. - 121.406(b). Specifically, your company/entity: (1) Does not exceed 500 employees (notice that the employee standard under the non-manufacturer rule may be more restrictive than for NAICS Code 541513); (2) Is primarily engaged in the retail or wholesale trade and normally sells the type of item being supplied; (3) Takes ownership or possession of the item(s) with its personnel, equipment or facilities in a manner consistent with industry practice; and (4) Will supply the end item of a small business manufacturer, processor, or producer made in the United States. NIH must receive written capability statements no later than December 13, 2017 at 9:00 a.m. Eastern Time. E-mail the written capability statement to Lisa Schaupp, the Contract Specialist, at the e-mail address contact@example.gov. Respondents will NOT be notified as to the results of the Government's market research.

Earlier notices in this NAICS code

Posted before this notice, open and closed

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS